Binding of the Calcium Antagonist Flunarizine to Phosphatidylcholine Bilayers: Charge Effects and Thermodynamics

Overview

Journal Biochem J

Specialty Biochemistry

Date 1993 Apr 15

PMID 8484720

Citations 7

Authors

P G Thomas

J Seelig

Affiliations

Soon will be listed here.

Abstract

We have examined the partitioning/transfer of the Ca2+ antagonist flunarizine from the aqueous phase into phospholipid bilayers. We show that the binding of the cationic amphiphilic drug flunarizine to phospholipid bilayers displays traditional linear concentration-dependent characteristics once unmasked of electrostatic effects. The coefficient for the binding/partitioning of flunarizine to phosphatidylcholine was found to be 28700 M-1, supporting the notion that this drug may be particularly membrane-active. The thermodynamics of the partitioning/transfer process have also been studied using high-sensitivity titration calorimetry. Binding was found to be predominantly enthalpy-driven with only a small entropic contribution; delta H = -22.1 kJ.mol-1 (-5.3 kcal.mol-1) at 27 degrees C. This is in conflict with established ideas of entropy-driven partitioning of drugs into phospholipid membranes as a result of the 'hydrophobic effect'. The strong enthalpic nature of binding is interpreted as being indicative of strong lipophilic interactions between the drug and the phospholipid phase.

Citing Articles

Bilayer composition, temperature, speciation effects and the role of bilayer chain ordering on partitioning of dexamethasone and its 21-phosphate.

Modi S, Anderson B Pharm Res. 2013; 30(12):3154-69.

PMID: 23884570 DOI: 10.1007/s11095-013-1143-z.

Accurate potentiometric determination of lipid membrane-water partition coefficients and apparent dissociation constants of ionizable drugs: electrostatic corrections.

Elsayed M, Vierl U, Cevc G Pharm Res. 2009; 26(6):1332-43.

PMID: 19283456 DOI: 10.1007/s11095-009-9842-1.

The thermodynamics of the partitioning of ionizing molecules between aqueous buffers and phospholipid membranes.

Austin R, Barton P, Davis A, Fessey R, Wenlock M Pharm Res. 2005; 22(10):1649-57.

PMID: 16180122 DOI: 10.1007/s11095-005-6336-7.

Interaction of antiinflammatory drugs with EPC liposomes: calorimetric study in a broad concentration range.

Matos C, Lima J, Reis S, Lopes A, Bastos M Biophys J. 2004; 86(2):946-54.

PMID: 14747330 PMC: 1303942. DOI: 10.1016/S0006-3495(04)74170-3.

Membrane recognition by vesicular stomatitis virus involves enthalpy-driven protein-lipid interactions.

Carneiro F, Bianconi M, Weissmuller G, Stauffer F, Da Poian A J Virol. 2002; 76(8):3756-64.

PMID: 11907215 PMC: 136106. DOI: 10.1128/jvi.76.8.3756-3764.2002.

References

Huang C, Charlton J . Interactions of phosphatidylcholine vesicles with 2-p-toluidinylnaphthalene-6-sulfonate. Biochemistry. 1972; 11(5):735-40. DOI: 10.1021/bi00755a010. View

Ross P, Subramanian S . Thermodynamics of protein association reactions: forces contributing to stability. Biochemistry. 1981; 20(11):3096-102. DOI: 10.1021/bi00514a017. View

Altenbach C, Seelig J . Ca2+ binding to phosphatidylcholine bilayers as studied by deuterium magnetic resonance. Evidence for the formation of a Ca2+ complex with two phospholipid molecules. Biochemistry. 1984; 23(17):3913-20. DOI: 10.1021/bi00312a019. View

Seelig A . Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers. Biochim Biophys Acta. 1987; 899(2):196-204. DOI: 10.1016/0005-2736(87)90400-7. View

Evans R, Williams M, Tinoco J . Surface areas of 1-palmitoyl phosphatidylcholines and their interactions with cholesterol. Biochem J. 1987; 245(2):455-62. PMC: 1148143. DOI: 10.1042/bj2450455. View

Seelig A, Allegrini P, Seelig J . Partitioning of local anesthetics into membranes: surface charge effects monitored by the phospholipid head-group. Biochim Biophys Acta. 1988; 939(2):267-76. DOI: 10.1016/0005-2736(88)90070-3. View

Miyazaki J, Hideg K, Marsh D . Interfacial ionization and partitioning of membrane-bound local anesthetics. Biochim Biophys Acta. 1992; 1103(1):62-8. DOI: 10.1016/0005-2736(92)90057-s. View

McLaughlin S . The electrostatic properties of membranes. Annu Rev Biophys Biophys Chem. 1989; 18:113-36. DOI: 10.1146/annurev.bb.18.060189.000553. View

Wiseman T, Williston S, Brandts J, Lin L . Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal Biochem. 1989; 179(1):131-7. DOI: 10.1016/0003-2697(89)90213-3. View

10.

Todd P, Benfield P . Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders. Drugs. 1989; 38(4):481-99. DOI: 10.2165/00003495-198938040-00002. View

11.

Thomas P, Verkleij A . The dissimilar interactions of the calcium antagonist flunarizine with different phospholipid classes and molecular species: a differential scanning calorimetry study. Biochim Biophys Acta. 1990; 1030(2):211-22. DOI: 10.1016/0005-2736(90)90297-2. View

12.

Bauerle H, Seelig J . Interaction of charged and uncharged calcium channel antagonists with phospholipid membranes. Binding equilibrium, binding enthalpy, and membrane location. Biochemistry. 1991; 30(29):7203-11. DOI: 10.1021/bi00243a023. View

13.

Seelig J, Ganz P . Nonclassical hydrophobic effect in membrane binding equilibria. Biochemistry. 1991; 30(38):9354-9. DOI: 10.1021/bi00102a031. View

14.

Hosey M, Lazdunski M . Calcium channels: molecular pharmacology, structure and regulation. J Membr Biol. 1988; 104(2):81-105. DOI: 10.1007/BF01870922. View